Clavister Q2’20: First Comments
Redeye will most likely lower current year forecasts, mainly as a result of Covid-19 related project delays. Even if recognised revenue came in short of expectations, strong order intake growth and billings should support growth in the coming quarters. Our base case is SEK 18. 0 per share.